UROGEN PHARMA LTD's ticker is URGN and the CUSIP is M96088105. A total of 60 filers reported holding UROGEN PHARMA LTD in Q2 2018. The put-call ratio across all filers is - and the average weighting 1.4%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2021 | $768,000 | +8.2% | 39,400 | 0.0% | 0.00% | 0.0% |
Q4 2020 | $710,000 | -8.4% | 39,400 | -2.0% | 0.00% | 0.0% |
Q3 2020 | $775,000 | -24.3% | 40,200 | +2.6% | 0.00% | 0.0% |
Q2 2020 | $1,024,000 | +37.1% | 39,200 | -6.4% | 0.00% | 0.0% |
Q1 2020 | $747,000 | -37.6% | 41,898 | +16.7% | 0.00% | 0.0% |
Q4 2019 | $1,198,000 | +159.3% | 35,900 | +85.1% | 0.00% | – |
Q3 2019 | $462,000 | -14.9% | 19,400 | +28.5% | 0.00% | -100.0% |
Q2 2019 | $543,000 | +6.5% | 15,100 | +9.4% | 0.00% | 0.0% |
Q1 2019 | $510,000 | -14.1% | 13,800 | 0.0% | 0.00% | 0.0% |
Q4 2018 | $594,000 | -18.6% | 13,800 | -10.7% | 0.00% | 0.0% |
Q3 2018 | $730,000 | -13.1% | 15,462 | -8.4% | 0.00% | 0.0% |
Q2 2018 | $840,000 | – | 16,885 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
ProQuest Associates IV LLC | 789,297 | $39,275,000 | 60.44% |
Wildcat Capital Management, LLC | 251,459 | $12,513,000 | 9.57% |
Consonance Capital Management LP | 1,487,491 | $74,018,000 | 4.77% |
MENORA MIVTACHIM HOLDINGS LTD. | 2,499,870 | $124,394,000 | 3.53% |
MEITAV INVESTMENT HOUSE LTD | 509,355 | $29,967,000 | 1.34% |
DSAM Partners (London) Ltd | 127,588 | $6,349,000 | 1.28% |
SHIKIAR ASSET MANAGEMENT INC | 48,125 | $2,395,000 | 1.00% |
BANK HAPOALIM BM | 67,125 | $3,340,000 | 0.91% |
HIGHLINE CAPITAL MANAGEMENT, L.P. | 331,900 | $16,515,000 | 0.55% |
Clal Insurance Enterprises Holdings Ltd | 310,000 | $15,426,000 | 0.40% |